Kemoterápia mellékhatások enyhítése – Gyógyszer kölcsönhatások

Kemoterápia mellékhatások enyhítése – Gyógyszer kölcsönhatások

1.

Evaluation of active hexose correlated compound hepatic metabolism and potential for drug interactions with chemotherapy agents.

Mach CM, Fugii H, Wakame K, Smith J.

J Soc Integr Oncol. 2008 Summer;6(3):105-9.

PMID: 19087767

2.

The influence of active hexose correlated compound (AHCC) on cisplatin-evoked chemotherapeutic and side effects in tumor-bearing mice.

Hirose A, Sato E, Fujii H, Sun B, Nishioka H, Aruoma OI.

Toxicol Appl Pharmacol. 2007 Jul 15;222(2):152-8. Epub 2007 Apr 20.

PMID: 17555784

3.

Importance of branched-chain amino acids in patients with liver cirrhosis and advanced hepatocellular carcinoma receiving hepatic arterial infusion chemotherapy.

Kanekawa T, Nagai H, Kanayama M, Sumino Y. Cancer Chemother Pharmacol. 2014 Nov;74(5):899-909. doi: 10.1007/s00280-014-2564-z. Epub 2014 Aug 20.

PMID: 25138286

4.

Host Immunity Influences the Efficacy of Combined Intra-Arterial Chemotherapy for Advanced Hepatocellular Carcinoma in Liver Cirrhosis Patients.

Nagai H, Mukouzu T, Matsui D, Kanekawa T, Matsui T, Kanayama M, Wakui N, Momiyama K, Shinohara M, Ishii K, Igarashi Y, Sumino Y. Hepatogastroenterology. 2014 May;61(131):741-6.

PMID: 26176067

5.

Reduction of adverse effects by a mushroom product, active hexose correlated compound (AHCC) in patients with advanced cancer during chemotherapy–the significance of the levels of HHV-6 DNA in saliva as a surrogate biomarker during chemotherapy.

Ito T, Urushima H, Sakaue M, Yukawa S, Honda H, Hirai K, Igura T, Hayashi N, Maeda K, Kitagawa T, Kondo K. Nutr Cancer. 2014;66(3):377-82. doi: 10.1080/01635581.2014.884232. Epub 2014 Mar 10.

PMID: 24611562

Suenaga S, Kuramitsu Y, Kaino S, Maehara S, Maehara Y, Sakaida I, Nakamura K.

Anticancer Res. 2014 Jan;34(1):141-6.

PMID: 24403454

6.

Active hexose-correlated compound down-regulates HSP27 of pancreatic cancer cells, and helps the cytotoxic effect of gemcitabine.

Love KM, Barnett RE, Holbrook I, Sonnenfeld G, Fujii H, Sun B, Peyton JC, Cheadle WG.

J Trauma Acute Care Surg. 2013 Jun;74(6):1411-8. doi: 10.1097/TA.0b013e31829215b1.

PMID:23694866

7.

Genotoxicity and subchronic toxicity evaluation of Active Hexose Correlated Compound (AHCC).

Fujii H, Nishioka N, Simon RR, Kaur R, Lynch B, Roberts A.

Regul Toxicol Pharmacol. 2011 Mar;59(2):237-50. doi: 10.1016/j.yrtph.2010.10.006. Epub 2010 Oct 14.

PMID: 20951179

8.

Alleviating effect of active hexose correlated compound (AHCC) for anticancer drug-induced side effects in non-tumor-bearing mice.

Shigama K, Nakaya A, Wakame K, Nishioka H, Fujii H.

J Exp Ther Oncol. 2009;8(1):43-51.

PMID: 19827270

9.

The effect of active hexose correlated compound in modulating cytosine arabinoside-induced hair loss, and 6-mercaptopurine- and methotrexate-induced liver injury in rodents.

Sun B, Wakame K, Sato E, Nishioka H, Aruoma OI, Fujii H.

Cancer Epidemiol. 2009 Oct;33(3-4):293-9. doi: 10.1016/j.canep.2009.07.006. Epub 2009 Aug 20.

PMID: 19699163

10.

Evaluation of active hexose correlated compound hepatic metabolism and potential for drug interactions with chemotherapy agents.

Mach CM, Fugii H, Wakame K, Smith J.

J Soc Integr Oncol. 2008 Summer;6(3):105-9.

PMID: 19087767

11.

Changes of host immunity in relation to efficacy in liver cirrhosis patients with advanced hepatocellular carcinoma treated by intra-arterial chemotherapy.

Momiyama K, Nagai H, Sumino Y.

Cancer Chemother Pharmacol. 2009 Jul;64(2):271-7. doi: 10.1007/s00280-008-0866-8. Epub 2008 Nov 15.

PMID: 19011857

12.

Influence of the etiology of liver cirrhosis on the response to combined intra-arterial chemotherapy in patients with advanced hepatocellular carcinoma.

Kanayama M, Nagai H, Sumino Y.

Cancer Chemother Pharmacol. 2009 Jun;64(1):109-14. doi: 10.1007/s00280-008-0851-2. Epub 2008 Nov 1.

PMID: 18979100

13.

Prognostic improvement of patients with advanced liver cancer after active hexose correlated compound (AHCC) treatment.

Cowawintaweewat S, Manoromana S, Sriplung H, Khuhaprema T, Tongtawe P, Tapchaisri P, Chaicumpa W.

Asian Pac J Allergy Immunol. 2006 Mar;24(1):33-45.

PMID: 16913187 Free Article

14.

H-2 haplotype-dependent serum IL-12 production in tumor-bearing mice treated with various mycelial extracts.

Yagita A, Maruyama S, Wakasugi S, Sukegawa Y.

In Vivo. 2002 Jan-Feb;16(1):49-54.

PMID: 11980361

15.

Suppressive effect of active hexose correlated compound (AHCC) on thymic apoptosis induced by dexamethasone in the rat.

Burikhanov RB, Wakame K, Igarashi Y, Wang S, Matsuzaki S.

Endocr Regul. 2000 Dec;34(4):181-8.

PMID: 11137978